PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 14 PubMed articles · model: gemma4:31b
Summary
Background
Active compounds
Mechanism of action
Clinical evidence
Flower extract reduced melanin and suppressed tyrosinase activity in B16F10 and normal human epidermal melanocyte cells [PMID:26702819].
Extracts and specific compounds (neopulchellin and 6α-hydroxyneopulchellin) demonstrated cytotoxicity against human breast (MCF7) and colon (HCT116) cancer cell lines [PMID:21846263]. Pulchelloid A was found to inhibit mitosis in human cells [PMID:34304367].
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 26702819 (2015) — Inhibition of melanogenesis by Gaillardia aristata flower extract. · BMC complementary and alternative medicine
- 2.PMID: 34304367 (2021) — Pulchelloid A, a sesquiterpene lactone from the Canadian prairie plant Gaillardia aristata inhibits mitosis in human cells. · Molecular biology reports
- 3.PMID: 7398279 (1980) — Dermatitis from Gaillardia aristata: Compositae dermatitis in South Australia. · Contact dermatitis
- 4.PMID: 21846263 (2012) — Cytotoxic compounds from the leaves of Gaillardia aristata Pursh. growing in Egypt. · Natural product research
- 5.PMID: 11683829 (2001) — Sensitization and cross-reaction patterns in Danish Compositae-allergic patients.